首页 | 本学科首页   官方微博 | 高级检索  
     

得舒特治疗肠易激综合征的临床疗效观察
引用本文:殳红进,陆红,刘文忠,黄大慰,张达荣,张德中. 得舒特治疗肠易激综合征的临床疗效观察[J]. 胃肠病学, 1998, 0(2)
作者姓名:殳红进  陆红  刘文忠  黄大慰  张达荣  张德中
作者单位:上海第二医科大学附属仁济医院,上海第二医科大学附属仁济医院,上海第二医科大学附属仁济医院,上海第二医科大学附属仁济医院,上海第二医科大学附属仁济医院,上海第二医科大学附属仁济医院 上海市消化疾病研究所 200001,上海市消化疾病研究所 200001,上海市消化疾病研究所 200001,上海市消化疾病研究所 200001,上海市消化疾病研究所 200001,上海市消化疾病研究所 200001
摘    要:目的:评价得舒特对肠易激综合征(IBS)的疗效。方法:56例根据罗马标准诊断为IBS的患者进入本研究。所有患者在服用得舒特治疗前一周服用安慰剂6天。安慰剂治疗无效的47例患者随后进入得舒特治疗,50mg,每日3次口服,疗程4周。结果:得舒特对肠易激综合征患者腹痛、腹泻和便秘单项症状的有效率分别为85.1%(40/47)、89.2%(33/37)和93.3%(14/15),对肠易激综合征的总有效率为85.1%(40/47)。治疗期间除2例诉头晕外,无其他不良反应。结论:得舒特治疗1BS疗效确切、副反应率低,临床上可作为治疗IBS的首选药物之一。

关 键 词:肠易激综合征  得舒特  分析

A Clinical Observation on Effectiveness of Dicetel in Treatment of Irritable Bowel Syndrome
Shu Hong-jin,Lu Hong,Liu Wen-zhong,el al. A Clinical Observation on Effectiveness of Dicetel in Treatment of Irritable Bowel Syndrome[J]. Chinese Journal of Gastroenterology, 1998, 0(2)
Authors:Shu Hong-jin  Lu Hong  Liu Wen-zhong  el al
Abstract:Background/Aims: To investigate the effectiveness of Dicetel, a calcium-channel blocker, in the treatment of the irritable bowel syndrome (IBS). Methods: Fifty six patients with IBS, diagnosed according to the Criteria of Roma, entered the study. All patients took placebo for six days in first week, only placebo-unresponder then received oral treatment of Dicetel 50mg tid for four weeks. Results: Total efficacy ra,tes for single symptom of IBS were as follows: abdominal pain 85.1% (40/47), diarrhea 89.2% (33/37) and constipation 93.3% (14/15). The global efficacy rate for IBS was 85.1% (40/47). During treatment, two patients complained of dizziness, and one of them was withdraw. Conclusions: Dicetel is highly effective and safe, and can be used as first-line drug for treatment of IBS.
Keywords:Dicetel Irritable bowel syndrome
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号